QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.5 % of QIAGEN's outstanding common shares at the end of 2016.
|Franklin Resources, Inc., United States||25,000||10.83|
|BlackRock, Inc., United States||19,000||8.23|
|PRIMECAP Management Company, United States||17,981||7.79|
Status: October 2017